Works matching IS 09395555 AND DT 2025 AND VI 104 AND IP 2

Results: 42
    1
    2
    3
    4
    5
    6

    A randomized, two-armed, double-blind, single-dose, cross-over, bioequivalence clinical trial to compare pharmacokinetic parameters and safety of recombinant human factor VIII with Fc fusion produced by AryoGen Pharmed Company versus Elocta<sup>®</sup> (reference product) in previously treated patients with severe haemophilia A

    Published in:
    Annals of Hematology, 2025, v. 104, n. 2, p. 1195, doi. 10.1007/s00277-025-06242-z
    By:
    • Eghbali, Aziz;
    • Eshghi, Peyman;
    • Toogeh, Gholamreza;
    • Alavi, Samin;
    • Badiei, Zahra;
    • Ghanavat, Majid;
    • Bordbar, Mohammadreza;
    • Bazrafshan, Asghar;
    • Karimi, Katayoon;
    • Ahmadinejad, Minoo;
    • Sabzvari, Araz;
    • Kafi, Hamidreza
    Publication type:
    Article
    7
    8

    Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myeloma.

    Published in:
    Annals of Hematology, 2025, v. 104, n. 2, p. 1177, doi. 10.1007/s00277-025-06240-1
    By:
    • Garcia-Guiñon, Antoni;
    • Charry, Paola Andrea;
    • Jimenez, María;
    • Sarra, Josep;
    • Delgado, Izarbe;
    • Segura de la Torre, Laura;
    • Santaliestra, Marta;
    • Garcia-Pintos, Marta;
    • Gonzalez, Yolanda;
    • Senin, Alicia;
    • Motlló, Cristina;
    • Abella, Eugènia;
    • Cabezudo, Elena;
    • Granell, Miquel;
    • Sancho, Esther;
    • Herranz, María José;
    • Seres, Yasmina;
    • Gironella, Mercedes;
    • Soler, Juan Alfons;
    • Marti-Tutusaus, Josep Maria
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Topological importance of CD8<sup>+</sup> T-cell enrichment in the tumor microenvironment of classic Hodgkin lymphoma.

    Published in:
    Annals of Hematology, 2025, v. 104, n. 2, p. 1047, doi. 10.1007/s00277-025-06189-1
    By:
    • Takahashi, Hiromichi;
    • Ito, Shun;
    • Nakanishi, Yoko;
    • Miura, Katsuhiro;
    • Nishimaki, Haruna;
    • Nakagawa, Masaru;
    • Otake, Shimon;
    • Hamada, Takashi;
    • Koike, Takashi;
    • Iizuka, Kazuhide;
    • Masuda, Shinobu;
    • Nakayama, Tomohiro;
    • Shimizu, Tetsuo;
    • Ishibashi, Naoya;
    • Kogure, Hirofumi;
    • Nakamura, Hideki
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Use of hydroxyurea in French-speaking Sub-Saharan Africa.

    Published in:
    Annals of Hematology, 2025, v. 104, n. 2, p. 937, doi. 10.1007/s00277-024-06180-2
    By:
    • Arlet, Jean-Benoît;
    • Bernaudin, Françoise;
    • Deme-Ly, Indou;
    • Coulibaly, Binta;
    • Corbasson, Anne;
    • Diagne, Ibrahima;
    • Diallo, Dapa;
    • Diop, Saliou;
    • Eposse, Charlotte;
    • Galacteros, Frédéric;
    • Hermine, Olivier;
    • Kafando, Eléonore;
    • Lainé, Agnès;
    • de Montalembert, Mariane;
    • Vodouhé, Constant;
    • Vovor, Ahoefa;
    • Ranque, Brigitte;
    • Tshilolo, Léon
    Publication type:
    Article
    29
    30

    Trends in the epidemiology of intravascular device-associated bacteremia among French hematology patients: insights from the SPIADI prospective multicenter study, 2020–2024.

    Published in:
    Annals of Hematology, 2025, v. 104, n. 2, p. 1231, doi. 10.1007/s00277-024-06154-4
    By:
    • van der Mee-Marquet, Nathalie;
    • Berger, Pierre;
    • Dussartre, Maris;
    • Valentin, Anne-Sophie;
    • Barbut, Frédéric;
    • Berrouane, Yasmina;
    • Brochart-Merlin, Julie;
    • Coroller Bec, Céline;
    • Cracco-Morel, Anne Adelaïde;
    • Darraillans, Nathalie;
    • Delorme, Martine;
    • Demasure, Maryvonne;
    • Galakhoff, Nicolas;
    • Huart, Claire;
    • Jeanne Leroyer, Camille;
    • Durand-Joly, Isabelle;
    • Laurans, Caroline;
    • Lefebvre, Annick;
    • Legeay, Clément;
    • Lemann, Florence
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38

    COVID-19 infection in children with blood cancer: A systematic review.

    Published in:
    Annals of Hematology, 2025, v. 104, n. 2, p. 1203, doi. 10.1007/s00277-024-06057-4
    By:
    • Alhumaid, Saad;
    • Al Noaim, Khalid;
    • Almuslim, Anwar A.;
    • Turkistani, Jamela A.;
    • Alqurini, Zainab Sabri;
    • Alshakhs, Abdullah Mohammed;
    • Al Dossary, Nourah;
    • Alabdulqader, Muneera;
    • Majzoub, Rabab Abbas;
    • Alnaim, Abdulrahman A.;
    • Alahmari, Abdulaziz A.;
    • Al Ghamdi, Mohammed A.;
    • Alabdulmohsen, Wafa;
    • Alsharidah, Zakaria Ali;
    • Alkhamees, Munther Saleh;
    • AlAithan, Laith Abbas;
    • Almurayhil, Abdulaziz Ahmed;
    • Almurayhil, Yousuf Ahmed;
    • Aljubran, Hassan Abdullah;
    • Alhamdan, Zahra Salman
    Publication type:
    Article
    39
    40
    41
    42

    Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study.

    Published in:
    Annals of Hematology, 2025, v. 104, n. 2, p. 1079, doi. 10.1007/s00277-024-05666-3
    By:
    • Dartigeas, Caroline;
    • Quinquenel, Anne;
    • Ysebaert, Loïc;
    • Dilhuydy, Marie-Sarah;
    • Anglaret, Bruno;
    • Slama, Borhane;
    • Le Du, Katell;
    • Tardy, Stéphanie;
    • Tchernonog, Emmanuelle;
    • Orfeuvre, Hubert;
    • Voillat, Laurent;
    • Guidez, Stéphanie;
    • Malfuson, Jean-Valère;
    • Dupuis, Sandrine;
    • Deslandes, Marine;
    • Feugier, Pierre;
    • Leblond, Véronique;
    • on behalf of the FIRE Investigators Group;
    • Adiko, Didier;
    • Agape, Philippe
    Publication type:
    Article